Greenbrook TMS Inc.
Greenbrook TMS Inc. (GBNH) Stock Overview
Explore Greenbrook TMS Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.5M
P/E Ratio
-0.03
EPS (TTM)
$-2.07
ROE
15.74%
GBNH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Greenbrook TMS Inc. (GBNH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.04.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 5.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
William P. Leonard
492
890 Yonge Street, Toronto, ON
2021